Financials data is unavailable for this security.
View more
Year on year Jaguar Health Inc has grown net income from a loss of -47.45m to a smaller loss of -41.30m despite falling revenues.
Gross margin | 79.79% |
---|---|
Net profit margin | -355.51% |
Operating margin | -263.27% |
Return on assets | -63.73% |
---|---|
Return on equity | -316.42% |
Return on investment | -110.34% |
More ▼
Cash flow in USDView more
In 2023, Jaguar Health Inc increased its cash reserves by 18.28%, or 1.00m. Cash Flow from Financing totalled 34.23m or 350.65% of revenues. In addition the company used 33.24m for operations while cash from investing was breakeven.
Cash flow per share | -22.26 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.48 |
---|---|
Tangible book value per share | -0.0021 |
More ▼
Balance sheet in USDView more
Current ratio | 2.10 |
---|---|
Quick ratio | 1.60 |
Total debt/total equity | 1.70 |
---|---|
Total debt/total capital | 0.6333 |
More ▼